These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21830537)

  • 1. [Tumor markers for diencephalon and pituitary diseases: urinary matrix metalloproteinases].
    Takano S
    Nihon Rinsho; 2011 Mar; 69 Suppl 2():155-9. PubMed ID: 21830537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suspected bladder carcinoma. New rapid test with high sensitivity].
    MMW Fortschr Med; 2002 Mar; 144(10):65. PubMed ID: 11928276
    [No Abstract]   [Full Text] [Related]  

  • 3. A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report.
    Smith ER; Manfredi M; Scott RM; Black PM; Moses MA
    Neurosurgery; 2007 Jun; 60(6):E1148-9; discussion E1149. PubMed ID: 17538362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase activity in urine of patients with renal cell carcinoma leads to degradation of extracellular matrix proteins: possible use as a screening assay.
    Sherief MH; Low SH; Miura M; Kudo N; Novick AC; Weimbs T
    J Urol; 2003 Apr; 169(4):1530-4. PubMed ID: 12629409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.
    Chan LW; Moses MA; Goley E; Sproull M; Muanza T; Coleman CN; Figg WD; Albert PS; Ménard C; Camphausen K
    J Clin Oncol; 2004 Feb; 22(3):499-506. PubMed ID: 14752073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of pituitary neoplasms: a review (Part II).
    Salehi F; Agur A; Scheithauer BW; Kovacs K; Lloyd RV; Cusimano M
    Neurosurgery; 2010 Dec; 67(6):1790-8; discussion 1798. PubMed ID: 21107210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence re: C. F. M. Sier et al., Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. Clin. Cancer Res., 6: 2333-2340, 2000.
    Gerhards S; Jung K; Koenig F; Daniltchenko D; Hauptmann S; Schnorr D; Loening SA
    Clin Cancer Res; 2001 Feb; 7(2):445-7. PubMed ID: 11234903
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.
    Moses MA; Harper J; Folkman J
    N Engl J Med; 2006 Jun; 354(24):2621-2. PubMed ID: 16775248
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary melanogen].
    Kobayashi Y; Adachi Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():779-81. PubMed ID: 16149639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
    He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
    Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases are elevated in the urine of patients with endometriosis.
    Becker CM; Louis G; Exarhopoulos A; Mechsner S; Ebert AD; Zurakowski D; Moses MA
    Fertil Steril; 2010 Nov; 94(6):2343-6. PubMed ID: 20378112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A pituitary tumor in a child].
    Cecile JP; Guaquière A; Fournier A; Cousin J; Laine E
    J Sci Med Lille; 1972 May; 90(5):211-5. PubMed ID: 5070326
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extracellular matrix metalloproteinases--perspectives of their use in medicine].
    Kotulska-Wolwender K; Larysz-Brysz M; Fus Z; Korczyńska I; Górka D; Lewin-Kowalik J
    Wiad Lek; 2002; 55(7-8):463-71. PubMed ID: 12428575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diencephalic syndrome of early infancy due to silent brain tumor: with special reference to treatment.
    Bain HW; Darte JM; Keith WS; Kruyff E
    Pediatrics; 1966 Sep; 38(3):473-82. PubMed ID: 5918397
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of cavernous hemangiome in the posterior pituitary lobe].
    Turhan B; Hachihanefioglu U
    Tip Fak Mecm; 1965; 28(4):366-71. PubMed ID: 5869202
    [No Abstract]   [Full Text] [Related]  

  • 16. A large cystic intrasellar and suprasellar tumor.
    Kuo LT; Huang WC; Yang CY; Huang SJ; Tu YK
    J Clin Neurosci; 2010 Oct; 17(10):1305, 1358. PubMed ID: 20737673
    [No Abstract]   [Full Text] [Related]  

  • 17. [EEG evaluation as cause of delayed brain tumor diagnosis].
    Schwarz HJ
    Psychiatr Neurol Med Psychol (Leipz); 1968 Nov; 20(11):416-20. PubMed ID: 5732728
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fundamental principles of the surgical treatment of neoplasms of chiasmal-sellar-diencephalic localization in children].
    Rostotskaia VI; Mareeva TG; Nersesiants SI; Artanian AA
    Vopr Neirokhir; 1971; 35(2):9-13. PubMed ID: 5106216
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain tumor and the Tree-test.
    Welman AJ
    Dis Nerv Syst; 1968 Sep; 29(9):593-8. PubMed ID: 4887391
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cystic ectopic pituitary adenoma: report of a case].
    Akimoto J; Nagura M; Onodera Y
    No To Shinkei; 1995 Nov; 47(11):1092-7. PubMed ID: 7495616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.